iKang Healthcare Group (KANG) Receiving Positive News Coverage, Report Finds
News coverage about iKang Healthcare Group (NASDAQ:KANG) has been trending positive recently, according to Accern. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. iKang Healthcare Group earned a media sentiment score of 0.36 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 45.7683722346844 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Separately, BidaskClub upgraded shares of iKang Healthcare Group from a “strong sell” rating to a “sell” rating in a report on Saturday.
iKang Healthcare Group (NASDAQ KANG) traded up 1.74% on Monday, reaching $14.04. 382,114 shares of the company traded hands. iKang Healthcare Group has a 52-week low of $11.70 and a 52-week high of $19.23. The stock’s market cap is $906.28 million.
iKang Healthcare Group (NASDAQ:KANG) last announced its quarterly earnings results on Thursday, June 22nd. The medical research company reported ($0.49) earnings per share for the quarter. iKang Healthcare Group had a negative net margin of 2.58% and a negative return on equity of 3.19%. The company had revenue of $60.16 million during the quarter. Equities analysts anticipate that iKang Healthcare Group will post $0.65 earnings per share for the current year.
About iKang Healthcare Group
iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.
Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.